Related Experiment Videos
Laboratory workup for osteoporosis. Which tests are most cost-effective?
1David Geffen School of Medicine at University of California, Los Angeles, USA. ccrandall@mednet.ucla.edu
Postgraduate Medicine
|September 25, 2003
Summary
Secondary osteoporosis often goes undetected due to a lack of clear lab testing guidelines. This review discusses screening controversies and cost-effective approaches for identifying contributing factors.
Area of Science:
- Endocrinology
- Bone Metabolism
- Geriatric Medicine
Background:
- Secondary causes of osteoporosis are frequently undiagnosed.
- Lack of specific laboratory evaluation guidelines hinders detection.
- Prevalence of non-menopausal contributing factors to osteoporosis is largely unknown.
Purpose of the Study:
- To discuss controversies in laboratory workup for newly diagnosed osteoporosis.
- To review studies on cost-effective screening for secondary osteoporosis.
- To address the diagnostic gap in osteoporosis etiology.
Main Methods:
- Literature review of existing studies on osteoporosis workup.
- Analysis of cost-effectiveness in screening protocols.
- Discussion of current guidelines and their limitations.
Main Results:
- Current guidelines for laboratory evaluation of osteoporosis are insufficient.
- Two studies suggest a cost-effective screening strategy is feasible.
- Identifying secondary causes can significantly impact patient management.
Conclusions:
- There is a need for standardized, evidence-based guidelines for osteoporosis laboratory testing.
- A targeted, cost-effective screening approach can improve the detection of secondary osteoporosis.
- Further research is warranted to refine screening protocols and improve patient outcomes.